View Older Stories View More Recent Stories

Jan 6, 2020 08:00AM Genprex to Present at Biotech Showcase™ 2020 in San Francisco
Nov 20, 2019 11:16AM Genprex (GNPX) Announces $1.26 Million Registered Direct Offering
Nov 20, 2019 11:15AM Genprex Announces $1.26 Million Registered Direct Offering
Nov 19, 2019 08:07AM Genprex (GNPX) Reports Positive Preclinical Data for Treatment of Some of the Most Resistant Metastatic Lung Cancers
Nov 19, 2019 08:00AM Genprex Reports Positive Preclinical Data for the Treatment of Some of the Most Resistant Metastatic Lung Cancers
Nov 4, 2019 08:00AM Genprex Issues Lung Cancer Prevention Measures in Support of Lung Cancer Awareness Month
Oct 9, 2019 08:00AM Genprex to Present at the MicroCap Rodeo Investor Conference
Oct 7, 2019 08:00AM Genprex’s Pioneering Use of Non-Viral Delivery for Gene Therapy is Gaining Industry Support
Sep 26, 2019 08:30AM Genprex (GNPX) Featured in Audio Publication Discussing New Research on Breast Cancer Treatment
Sep 25, 2019 08:30AM Genprex (GNPX) Featured in Publication on Advances in Potential Breast Cancer Treatments
Sep 18, 2019 08:00AM Genprex to Present Via Webcast at the Singular Research Midwestern Values Conference on September 19, 2019
Sep 11, 2019 08:00AM Independent Researchers Find Genprex’s TUSC2 Prevents Tumor Growth in Triple-Negative Breast Cancer
Sep 7, 2019 04:35PM CORRECTING and REPLACING Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Sep 6, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments
Sep 6, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments
Sep 5, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer
Sep 5, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer
Sep 5, 2019 08:00AM Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Sep 3, 2019 08:00AM Genprex Provides Forward Looking Guidance and Updates on Corporate Activities, Publishes New Corporate Deck
Aug 23, 2019 08:30AM Genprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech Sector
Aug 23, 2019 08:30AM Genprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech Sector
Aug 22, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone Achievements
Aug 22, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone Achievements
Aug 21, 2019 08:00AM Genprex to Present at the RHK Capital 4th Annual Disruptive Growth Conference
Aug 13, 2019 08:00AM Genprex Demonstrates Growth and Expansion Through Recent Achievements
Aug 6, 2019 08:00AM Genprex™ Manufacturing Partner Aldevron Completes Significant Step in Manufacturing for Oncoprex™ Clinical Development Program
Jul 31, 2019 08:30AM Genprex Begins Next Phase of Drug Branding Program
Jul 1, 2019 08:30AM Genprex Provides Update on Development of its Oncoprex Immunogene Therapy in Combination with Immunotherapy for Non-Small Cell Lung Cancer
May 31, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
May 31, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
May 30, 2019 08:35AM Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Hunt for Gene Therapy Breakthroughs  
May 30, 2019 08:35AM Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Hunt for Gene Therapy Breakthroughs  
May 21, 2019 08:30AM Genprex to Present at Sachs 5th Annual Immuno-Oncology BD&L and Investment Forum
May 9, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
May 9, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
May 8, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Gene Therapies for Cancer Treatment
May 8, 2019 08:30AM Genprex Retains Addison Whitney for Drug Nomenclature Branding
Apr 12, 2019 09:00AM Genprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the Incurable
Apr 11, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Cancer and Gene Therapy Treatment
Apr 8, 2019 08:30AM Genprex Collaborators Report Positive TUSC2 and Checkpoint Blockade Preclinical Data at the 2019 AACR Annual Meeting
Apr 1, 2019 08:30AM Genprex Provides Clinical, Corporate, and Financial Update for the Year Ending December 31, 2018
Mar 29, 2019 09:00AM Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Advanced Medical Cancer Therapy
Mar 28, 2019 08:30AM Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Innovative Cancer Treatments
Mar 19, 2019 08:30AM Genprex Inc. Discusses Plans to Expand Clinical Trials in Fight Against Cancer in Exclusive Audio Interview with NetworkNewsWire
Mar 14, 2019 08:30AM Genprex to Present at ARM Cell & Gene Therapy Investor Day in New York City
Feb 27, 2019 08:30AM Genprex Strengthens Senior Team and Continues to Advance Operations
Feb 19, 2019 08:34AM Genprex (GNPX) Announces John N. Bonfiglio PhD to Board
Feb 19, 2019 08:30AM Genprex Appoints John N. Bonfiglio, PhD, to Board of Directors
Jan 23, 2019 08:30AM Genprex to Present at NobleConXV in Fort Lauderdale, Florida
Jan 3, 2019 08:30AM Genprex to Present at Biotech Showcase™ 2019 in San Francisco
View More Recent Stories View Older Stories